Abstract
To evaluate the relationship between Chlamydia pneumoniae infection and lung cancer, we conducted a metaanalysis of studies comparing the antibodies of C. pneumoniae between lung cancer patients and controls. The random-effects model or fixed-effects model was used according to the results of heterogeneity tests. Total, 8 studies with 1602 cases and 1734 controls were included. The analysis showed that the pooled OR of the association between C. pneumoniae IgA and lung cancer was 1.82 (95% CI, 1.21-2.74), while the association between C. pneumoniae IgG and lung cancer was 1.77 (95% CI, 1.13-2.78). Thus, statistically significant differences were observed between C. pneumoniae antibodies and lung cancer. This meta-analysis suggests that C. pneumoniae infection may be a potential risk factor for lung cancer.
Keywords: Chlamydia pneumoniae, lung cancer, meta-analysis
Current Respiratory Medicine Reviews
Title: Association Between Chlamydia pneumoniae Antibodies and Lung Cancer: A Meta-Analysis
Volume: 6 Issue: 3
Author(s): Zhuang Liu, Zhi-hua Yin, Hui-ying Liang, Zhi-fang Jia and Bao-sen Zhou
Affiliation:
Keywords: Chlamydia pneumoniae, lung cancer, meta-analysis
Abstract: To evaluate the relationship between Chlamydia pneumoniae infection and lung cancer, we conducted a metaanalysis of studies comparing the antibodies of C. pneumoniae between lung cancer patients and controls. The random-effects model or fixed-effects model was used according to the results of heterogeneity tests. Total, 8 studies with 1602 cases and 1734 controls were included. The analysis showed that the pooled OR of the association between C. pneumoniae IgA and lung cancer was 1.82 (95% CI, 1.21-2.74), while the association between C. pneumoniae IgG and lung cancer was 1.77 (95% CI, 1.13-2.78). Thus, statistically significant differences were observed between C. pneumoniae antibodies and lung cancer. This meta-analysis suggests that C. pneumoniae infection may be a potential risk factor for lung cancer.
Export Options
About this article
Cite this article as:
Liu Zhuang, Yin Zhi-hua, Liang Hui-ying, Jia Zhi-fang and Zhou Bao-sen, Association Between Chlamydia pneumoniae Antibodies and Lung Cancer: A Meta-Analysis, Current Respiratory Medicine Reviews 2010; 6 (3) . https://dx.doi.org/10.2174/157339810791526111
DOI https://dx.doi.org/10.2174/157339810791526111 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Roles of Tumor Microenvironment in Hepatocelluar Carcinoma
Current Cancer Therapy Reviews Anticancer Therapeutic Strategies Based on CDK Inhibitors
Current Pharmaceutical Design Malignant Pleural Effusion Evaluation and Management
Current Respiratory Medicine Reviews The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity
Current Drug Metabolism Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer
Current Cancer Drug Targets Patent Selections
Recent Patents on Biomarkers ras Genes and Human Cancer: Different Implications and Different Roles
Current Genomics Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer
Current Medicinal Chemistry Anti-Cancer/Anti-Tumor
Current Bioactive Compounds Current Drug Therapy for Prostate Cancer: An Overview
Current Medicinal Chemistry - Anti-Cancer Agents Chemical & RNAi Screening at MSKCC: A Collaborative Platform to Discover & Repurpose Drugs to Fight Disease
Combinatorial Chemistry & High Throughput Screening Exploring the Management of Statin Intolerant Patients: 2016 and Beyond
Current Vascular Pharmacology Relevance of Drug Metabolizing Enzyme Activity Modulation by Tea Polyphenols in the Inhibition of Esophageal Tumorigenesis
Medicinal Chemistry A Novel Sequence-Based Method for Phosphorylation Site Prediction with Feature Selection and Analysis
Protein & Peptide Letters Mikuliczs Disease and its Extraglandular Lesions
Current Immunology Reviews (Discontinued) To Die or Not to Die: That is the Autophagic Question
Current Molecular Medicine Natural Products as PI3K/ Akt Inhibitors: Implications in Preventing Hepatocellular Carcinoma
Current Molecular Pharmacology Targeting P-glycoprotein for Effective Oral Anti-Cancer Chemotherapeutics
Current Cancer Drug Targets Preface:
Current Molecular Pharmacology Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay
Current Drug Targets